Global Bioenergies SA
PAR:ALGBE
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.4875
2.16
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Global Bioenergies SA
Net Margin
Global Bioenergies SA
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | FR |
| Market Cap | 15m EUR |
| Net Margin |
-1 514%
|
| Country | SA |
| Market Cap | 228.3B SAR |
| Net Margin |
-2%
|
| Country | ID |
| Market Cap | 43.8B USD |
| Net Margin |
-4%
|
| Country | ID |
| Market Cap | 620.7T IDR |
| Net Margin |
-4%
|
| Country | US |
| Market Cap | 31.2B USD |
| Net Margin |
2%
|
| Country | UK |
| Market Cap | 26.7B USD |
| Net Margin |
5%
|
| Country | KR |
| Market Cap | 23.9T KRW |
| Net Margin |
1%
|
| Country | US |
| Market Cap | 16.5B USD |
| Net Margin |
1%
|
| Country | CN |
| Market Cap | 99.3B CNY |
| Net Margin |
3%
|
| Country | CN |
| Market Cap | 90.5B CNY |
| Net Margin |
1%
|
| Country | IN |
| Market Cap | 926B INR |
| Net Margin |
15%
|
Global Bioenergies SA
Glance View
Global Bioenergies SA develops industrial processes to convert renewable sources into isobutene. The company is headquartered in Evry, Ile-De-France. The company went IPO on 2011-06-09. Isobutene, a hydrocarbon, can be converted into fuels such as isooctane, as well as into various materials (synthetic rubber, organic glass, plastics). The process developed by Global Bioenergies SA is based on the design of an artificial metabolic pathway comprising several enzymes catalyzing reactions not observed in nature. Six patent applications have been filed by the Company. The first two applications covering the key steps of the bio-production of isobutene and other olefins have already been published. The company distributes butane and propane containing bio-isobutene, in a e partnership with Global Bioenergies. The company operates through Syngip.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Global Bioenergies SA's most recent financial statements, the company has Net Margin of -1 514.5%.
You don't have any saved screeners yet
